10.54% operating margin is respectable but not wide. ROIC at 14.08%. Suggests the business covers its cost of capital, but doesn't point to a wide moat.
Revenue grew 20.2%, still solid. Margins contracted 3.4pp, which offsets some of the top-line progress.
ROIC dropped from 19.92% to 14.08%, capital efficiency is deteriorating. Operating margin contracted 3.4pp YoY, cost discipline may be slipping.
10.3x earnings. The multiple is below average. Either the market is pricing in deterioration you should investigate, or there's genuine value here.
Price History
Valuation & Multiples
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
$2.60B
▲ +20.2% YoY
Net Income (TTM)
$275M
▲ +2159.1% YoY
Op. Margin
8.97%
▼ -3.4pp YoY
ROIC
12.09%
▼ -5.8pp YoY
Cash Flow & Balance Sheet
FCF
N/A
Op. Cash Flow (TTM)
$168M
▲ +285.6% YoY
Net Debt
$1.24B
Cash & Equiv.
$97M
5Y CAGR: +10.2%
Continue Research
SourceComputed from the 10-Q filed 7 Aug 2026, covering the period ending 4 Jul 2026, as reported to the SEC. Data last refreshed 14 Aug 2026. How this is calculated.
Price from market data, last close as of 21 Oct 2026. Fiscal year ends Jan. Sector medians are approximate S&P 500 benchmarks and update periodically.
Is Aveanna Healthcare Holdings (AVAH) overvalued?
At a P/E of 10.3, Aveanna Healthcare Holdings (AVAH)'s valuation is best read against its own history, its peers, and the growth its price implies. A high multiple is not the same as overvalued: fast-growing, high-quality businesses can deserve a premium. See the general approach in how to tell if a stock is overvalued.
On quality, Aveanna Healthcare Holdings scores 41/100 on Intrinsiqq's quality scorecard (a mixed business on these measures), weighing growth, margins, returns on capital, share count, and balance-sheet strength. All figures are computed from SEC filings; read the full methodology, or see how the market compares in our US profitability statistics. This is analysis, not investment advice.
Frequently asked
Is Aveanna Healthcare Holdings a high-quality business?+
Aveanna Healthcare Holdings scores 41 out of 100 on Intrinsiqq's quality score, a weighted blend of 6 metrics each scored 0 to 100, which makes it a mixed business on these measures. Recent fundamentals include a 9.0% operating margin and a 12.1% return on invested capital. The score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, share-count change, and balance-sheet strength, all computed from SEC filings, not opinion. Because valuation only means something relative to quality, the full metric-by-metric breakdown is on the quality scorecard.
Is Aveanna Healthcare Holdings a good stock to buy right now?+
That depends on valuation and quality together, not either alone. you should weigh AVAH's valuation and scores 41/100 on quality (mixed). A cheap price is only a bargain if the business is durable, and a premium can be justified by genuine quality, so the two questions, "is it cheap?" and "is it good?", only make sense side by side. Read the valuation against the quality scorecard, run the DCF on your own assumptions, and decide for yourself. This is analysis from SEC filings, not investment advice.
Related stocks: Services-Home Health Care Services
Spot a number that looks wrong? Check it in AVAH's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing AVAH
Create a free account and get 14 days of Premium: every stock and every tool.
- Unlimited stocks
- Stock screener
- Portfolio tracker
- Editable DCF
- Compare side by side
- Unlimited alerts
No card. Moves to Free after, unless you upgrade.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.